Overhaul in pharma manufacturing: India imposes stringent quality controls.
Source: Business Line Concerns raised by health authorities and non-compliance with international standards have prompted this push, with large companies given a six-month deadline and smaller ones a 12-month timeframe to comply. India has tightened rules to ensure mandatory compliance with good manufacturing practices – which looks at bringing in quality control on materials, machines, […]
Implementing revised Schedule M rules uphill task for small pharma
Source: Business Standard A notification of the revised Schedule M rules by the Ministry of Health and Family Welfare has elicited mixed responses from the pharma sector and industry observers. While the industry has welcomed the revision of rules, several analysts said that implementation and compliance can become a challenge for smaller pharmaceutical companies. The […]